Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
US10221142B2 · kind B2 · utility
3Cited by
44References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2016 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Feb 11, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds according to Formula (I-1) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.